128 related articles for article (PubMed ID: 38342436)
1. Loss of function and reduced levels of sphingolipid desaturase DEGS1 variants are both relevant in disease mechanism.
Dei Cas M; Montavoci L; Pasini C; Caretti A; Penati S; Martinelli C; Gianelli U; Casati S; Nardecchia F; Torella A; Brunetti-Pierri N; Trinchera M
J Lipid Res; 2024 Mar; 65(3):100517. PubMed ID: 38342436
[TBL] [Abstract][Full Text] [Related]
2. Rare
Blackburn NB; Michael LF; Meikle PJ; Peralta JM; Mosior M; McAhren S; Bui HH; Bellinger MA; Giles C; Kumar S; Leandro AC; Almeida M; Weir JM; Mahaney MC; Dyer TD; Almasy L; VandeBerg JL; Williams-Blangero S; Glahn DC; Duggirala R; Kowala M; Blangero J; Curran JE
J Lipid Res; 2019 Sep; 60(9):1630-1639. PubMed ID: 31227640
[TBL] [Abstract][Full Text] [Related]
3. Dihydroceramide desaturase regulates the compartmentalization of Rac1 for neuronal oxidative stress.
Tzou FY; Su TY; Lin WS; Kuo HC; Yu YL; Yeh YH; Liu CC; Kuo CH; Huang SY; Chan CC
Cell Rep; 2021 Apr; 35(2):108972. PubMed ID: 33852856
[TBL] [Abstract][Full Text] [Related]
4. The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy.
Hülsmeier AJ; Toelle SP; Bellstedt P; Wentzel C; Bahr A; Kolokotronis K; Hornemann T
J Lipid Res; 2023 Dec; 64(12):100464. PubMed ID: 37890668
[TBL] [Abstract][Full Text] [Related]
5. Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
Rodriguez-Cuenca S; Barbarroja N; Vidal-Puig A
Biochim Biophys Acta; 2015 Jan; 1851(1):40-50. PubMed ID: 25283058
[TBL] [Abstract][Full Text] [Related]
6. Dihydroceramide Δ4-Desaturase 1 Is Not Involved in SARS-CoV-2 Infection.
Hayashi Y; Matsuda K; Tanigawa K; Tanikawa T; Maeda K; Tsuchiya K
Biol Pharm Bull; 2022; 45(10):1559-1563. PubMed ID: 36184516
[TBL] [Abstract][Full Text] [Related]
7. Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity.
Planas-Serra L; Launay N; Goicoechea L; Heron B; Jou C; Juliá-Palacios N; Ruiz M; Fourcade S; Casasnovas C; De La Torre C; Gelot A; Marsal M; Loza-Alvarez P; García-Cazorla À; Fatemi A; Ferrer I; Portero-Otin M; Area-Gómez E; Pujol A
J Clin Invest; 2023 May; 133(10):. PubMed ID: 36951944
[TBL] [Abstract][Full Text] [Related]
8. DEGS1 -related leukodystrophy: a clinical report and review of literature.
Wong MST; Thomas T; Lim JY; Kam S; Teo JX; Ching J; Goh CYJ; Jamuar SS; Lim WK; Koh AL
Clin Dysmorphol; 2023 Jul; 32(3):106-111. PubMed ID: 37195341
[TBL] [Abstract][Full Text] [Related]
9. Gamma-tocotrienol profoundly alters sphingolipids in cancer cells by inhibition of dihydroceramide desaturase and possibly activation of sphingolipid hydrolysis during prolonged treatment.
Jang Y; Rao X; Jiang Q
J Nutr Biochem; 2017 Aug; 46():49-56. PubMed ID: 28456081
[TBL] [Abstract][Full Text] [Related]
10. Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage.
Molendijk J; Kolka CM; Cairns H; Brosda S; Mohamed A; Shah AK; Brown I; Hodson MP; Hennessy T; Liu G; Stoll T; Richards RS; Gartside M; Patel K; Clemons NJ; Phillips WA; Barbour A; Westerhuis JA; Hill MM
Clin Transl Med; 2022 May; 12(5):e810. PubMed ID: 35560527
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiological role of dihydroceramide desaturase in the nervous system.
Tzou FY; Hornemann T; Yeh JY; Huang SY
Prog Lipid Res; 2023 Jul; 91():101236. PubMed ID: 37187315
[TBL] [Abstract][Full Text] [Related]
12. Dihydroceramide desaturase knockdown impacts sphingolipids and apoptosis after photodamage in human head and neck squamous carcinoma cells.
Breen P; Joseph N; Thompson K; Kraveka JM; Gudz TI; Li L; Rahmaniyan M; Bielawski J; Pierce JS; VAN Buren E; Bhatti G; Separovic D
Anticancer Res; 2013 Jan; 33(1):77-84. PubMed ID: 23267130
[TBL] [Abstract][Full Text] [Related]
13. Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function.
Barbarroja N; Rodriguez-Cuenca S; Nygren H; Camargo A; Pirraco A; Relat J; Cuadrado I; Pellegrinelli V; Medina-Gomez G; Lopez-Pedrera C; Tinahones FJ; Symons JD; Summers SA; Oresic M; Vidal-Puig A
Diabetes; 2015 Apr; 64(4):1180-92. PubMed ID: 25352638
[TBL] [Abstract][Full Text] [Related]
14. Loss of the sphingolipid desaturase DEGS1 causes hypomyelinating leukodystrophy.
Pant DC; Dorboz I; Schluter A; Fourcade S; Launay N; Joya J; Aguilera-Albesa S; Yoldi ME; Casasnovas C; Willis MJ; Ruiz M; Ville D; Lesca G; Siquier-Pernet K; Desguerre I; Yan H; Wang J; Burmeister M; Brady L; Tarnopolsky M; Cornet C; Rubbini D; Terriente J; James KN; Musaev D; Zaki MS; Patterson MC; Lanpher BC; Klee EW; Pinto E Vairo F; Wohler E; Sobreira NLM; Cohen JS; Maroofian R; Galehdari H; Mazaheri N; Shariati G; Colleaux L; Rodriguez D; Gleeson JG; Pujades C; Fatemi A; Boespflug-Tanguy O; Pujol A
J Clin Invest; 2019 Mar; 129(3):1240-1256. PubMed ID: 30620337
[TBL] [Abstract][Full Text] [Related]
15. Dihydroceramide desaturase and dihydrosphingolipids: debutant players in the sphingolipid arena.
Fabrias G; Muñoz-Olaya J; Cingolani F; Signorelli P; Casas J; Gagliostro V; Ghidoni R
Prog Lipid Res; 2012 Apr; 51(2):82-94. PubMed ID: 22200621
[TBL] [Abstract][Full Text] [Related]
16. DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humans.
Karsai G; Kraft F; Haag N; Korenke GC; Hänisch B; Othman A; Suriyanarayanan S; Steiner R; Knopp C; Mull M; Bergmann M; Schröder JM; Weis J; Elbracht M; Begemann M; Hornemann T; Kurth I
J Clin Invest; 2019 Mar; 129(3):1229-1239. PubMed ID: 30620338
[TBL] [Abstract][Full Text] [Related]
17. DEGS1 variant causes neurological disorder.
Dolgin V; Straussberg R; Xu R; Mileva I; Yogev Y; Khoury R; Konen O; Barhum Y; Zvulunov A; Mao C; Birk OS
Eur J Hum Genet; 2019 Nov; 27(11):1668-1676. PubMed ID: 31186544
[TBL] [Abstract][Full Text] [Related]
18. Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells.
Zhu Y; Cho K; Lacin H; Zhu Y; DiPaola JT; Wilson BA; Patti GJ; Skeath JB
bioRxiv; 2024 May; ():. PubMed ID: 38260379
[TBL] [Abstract][Full Text] [Related]
19. Native and Polyubiquitinated Forms of Dihydroceramide Desaturase Are Differentially Linked to Human Embryonic Kidney Cell Survival.
Alsanafi M; Kelly SL; Jubair K; McNaughton M; Tate RJ; Merrill AH; Pyne S; Pyne NJ
Mol Cell Biol; 2018 Dec; 38(23):. PubMed ID: 30224516
[TBL] [Abstract][Full Text] [Related]
20. Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro.
Siddique MM; Bikman BT; Wang L; Ying L; Reinhardt E; Shui G; Wenk MR; Summers SA
PLoS One; 2012; 7(9):e44042. PubMed ID: 22984457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
